Metabolic syndrome and prediabetes identify overlapping but not identical populations

Experimental and Clinical Endocrinology and Diabetes

Volumn 114, Issue 7, 2006, Pages 377-383

  Diamantopoulos, Emannuel J ^a,c   Andreadis, E A ^a   Tsourous, G I ^a   Ifanti, G K ^a   Katsanou, P M ^a   Georgiopoulos, D X ^a   Vassilopoulos, C V ^a   Dimitriadis, G ^b   Raptis, S A ^b  

^a EVANGELISMOS HOSPITAL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

CARMOS Study; Carotid intima media thickness; Metabolic syndrome; Microalbuminuria; Prediabetes

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEMOGRAPHY; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; PRIORITY JOURNAL; PULSE WAVE;

ADULT; AGED; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MEDICAL HISTORY TAKING; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OVERWEIGHT; PREDIABETIC STATE;

EID: 33747604604     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-924319     Document Type: Article

References (31)

1. American Diabetes Association. Prediabetes. Clinical Practice Recommendations, 2004. Diabetes Care 2004; 27: 5-10
2. Calle EE, Thun MJ, Petrelli JM, Rodriguez C et al. Body mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105
3. Chobanian AV, Bakris GL, Black H et al. Seventh Report Of The Joint National Committee On Prevention. Detection, Evaluation, And Treatment Of High Blood Pressure. Hypertension 2003; 42: 1206-1252
4. Cuspidi C, Meani S, Fusi V et al. Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 2004; 22: 1991-1998
5. Declerck PJ, Alessi MC, Verstreken M et al. Measurement of plasminogen activator inhibitor-1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71: 220-225
6. Grundy SM, Brewer B Jr, Cleeman JI et al. Definition of metabolic syndrome. Report of the National Heart, Lung and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition. Circulation 2004; 109: 433-438
7. Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977; 55: 613-618
8. Diamantopoulos EJ, Andreadis E, Kakou M et al. Atherosclerosis of carotid arteries and the ACE insertion/deletion polymorphism in subjects with diabetes mellitus type 2. Int Angiol 2002; 21: 63-69
9. Meigs JB, Nathan DM, D'Agostino RB, Wilson PWF. Fasting and post-challenge glycemia and cardiovascular risk: the Framigham offspring study. Diabetes Care 2002; 25: 1845-1850
10. Ferrannini E, Vichi S, Nielsen HB et al. Insulin action and age. European Group for the Study of Insulin Resistance (ECIR). Diabetes 1996; 45: 947-953
11. Filiposky J, Svobodorova V. Pecen L. Reproducibility of radial pulse wave analysis in healthy subjects. J Hypertension 2000; 18: 1033-1040
12. Hanefeld M, Koehler C, Fuecker K et al. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2003; 26: 868-874
13. Horio T, Miyazato J, Kamide K et al. Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diasiolic function in essential hypertension. Am J Hypertens 2003; 16: 938-944
14. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middled-aged men. JAMA 2002; 288: 2709-2716
15. Lind L, Anderson PE, Andren B et al. Left ventricular hypertrophy in hypertension is associated with insulin resistance metabolic syndrome. J Hypertens 1995; 13: 433-438
16. Matthews DR, Hosker JD, Rudenski AS et al. Homeostasis model assessment: insulin resistance and β cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1989; 28: 412-419
17. Meigs JB, Ken Williams MS, Sullivan LM et al. Using metabolic syndrome traits for efficient detection of impaired glucose tolerance. Diabetes Care 2004; 27: 132-138
18. Mullan BA, Young IS, Fee H et al. Ascorbic acid reduces blood pressure and arterial stiffness in type 2 diabetes. Hypertension 2002; 40: 804-809
19. Pedrinelli R, Dell' Omo G, Penno G et al. Microalbuminuria, a parameter independent of metabolic influences in hypertensive men. J Hypertens 2003; 21: 1163-1169
20. Philips PI, Clark PM. Hales CN et al. Understanding oral glucose tolerance test: comparison of glucose and insulin measurements during the OGTT with specific measurements of insulin resistance and secretion. Diabet Med 1994; 11: 286-292
21. Rutter MK, Meigs JB, Sullivan LM et al. C-reactive protein, the metabolic syndrome and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004; 110: 380-385
22. Sahn DJ, De Maria A, Kisslo J et al. Recommendations regarding quantification in M-Mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-1083
23. Schram MT, Henry RM, vanDijk RA et al. Increased central artery stifness in impaired glucose metabolism and type 2 diabetes. The Hoorn Study. Hypertension 2004; 43: 176-181
24. SERA-PAK immune Microalbumin. Publication No. TL9-6932K96, Bayer Corporation, 1996
25. Sowers JR, Frohlich ED. Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Medical Clinics of North America 2004; 88: 63-82
26. Stern MP. Diabetes and cardiovascular disease. The "common soil" hypothesis. Diabetes 1995; 44: 369-374
27. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up Report on the Diagnosis of Diabetes Mellitus. Diabetes Care 2003; 26: 3160-3167
28. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002; 106: 3143-3421
29. Watanabe S, Okura T, Kitami Y et al. Carotid hemodynamic alterations in hypertensive patients with insulin resistance. Am J Hypertension 2002; 15: 851-856
30. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzerland: World Health Organization; 1999. Available at: http://whqlibloc.who.int/hq/1999/WHO- NCD-NCS-992.pdf. Accessed December 12, 2003
31. Zimmet P, Alberti KG, Swaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787